Skip to main content

Table 4 Difference in sPSA detection rate due to previous endocrine therapy (n = 58)

From: Clinical significance of serum PSA in breast cancer patients

  n sPSA positive (%) sPSA negative (%) p value
Aromatase inhibitor resistance 0.1389
 Yes 37 16 (43.2) 21 (56.8)  
 No 21 5 (23.8) 16 (76.2)
SERM resistance 0.4584
 Yes 23 7 (30.4) 16 (69.6)  
 No 35 14 (40.0) 21 (60.0)
SERD resistance 0.2643
 Yes 12 6 (50.0) 6 (50.0)  
 No 46 15 (32.6) 31 (67.4)
\